Chu Yu-Waye
Chief Medical Officer at CTMX; Officer at FATE
- Sold, on record
- $1.2M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Mar 17, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale FATEPlan not statedDec 10, 2021 2021
Sold 7,500 shares at $51.46 ($386k)
Chu Yu-Waye, Senior VP Clinical Development
Sold 5.6% of holdings ($6.9M position)125,758 shares leftFiling
- 2 Form 4 sale FATEPlan not statedJan 11, 2022 +32 days
Sold 3,965 shares at $48.51 ($192k)
Chu Yu-Waye, Senior VP Clinical Development
Sold 3.2% of holdings ($6.1M position)121,793 shares leftFiling
- 3 Form 4 sale FATEPlan not statedApr 19, 2022 +98 days
Sold 4,062 shares at $35.37 ($144k)
Chu Yu-Waye, Chief Medical Officer
Sold 2.6% of holdings ($5.5M position)151,033 shares left1x usual sizeFiling
- 4 Form 4 sale FATEPlan not statedJan 10, 2023 +266 days
Sold 7,825 shares at $5.24 ($41k)
Chu Yu-Waye, Chief Medical Officer
Sold 5.2% of holdings ($791k position)143,208 shares left1.9x usual sizeFiling
- 5 Form 144 notice FATENoticeApr 18, 2023 +98 days
Filed to sell 2,532 shares ($17k)
Chu Yu-Waye, Officer
No 10b5-1 plan0.4x usual sizeFiling
- 6 Form 4 sale FATERoutineApr 18, 2023 same day
Sold 2,532 shares at $6.57 ($17k)
Chu Yu-Waye, Chief Medical Officer
10b5-1 planSold 1.8% of holdings ($942k position)140,676 shares left0.4x usual sizeFollows a Form 144Filing
- 7 Form 4 sale CTMXNo planMar 18, 2025 +700 days
Sold 4,025 shares at $0.60 ($2k)
Chu Yu-Waye, Chief Medical Officer
No 10b5-1 planSold 2.9% of holdings ($84k position)135,725 shares leftFirst sale on recordFiling
- 8 Form 4 sale CTMXNo planMar 17, 2026 +364 days
Sold 21,279 shares at $6.42 ($137k)
Chu Yu-Waye, Chief Medical Officer
No 10b5-1 planSold 10.1% of holdings ($1.4M position)189,446 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | Mar 19, 2026 | CTMX | Chief Medical Officer | Form 4 sale | 21,279 | $137k | 10.1% | No plan | SEC |
| Mar 18, 2025 | Mar 20, 2025 | CTMX | Chief Medical Officer | Form 4 sale | 4,025 | $2k | 2.9% | No plan | SEC |
| Apr 18, 2023 | Apr 19, 2023 | FATE | Chief Medical Officer | Form 4 sale | 2,532 | $17k | 1.8% | Routine | SEC |
| Apr 18, 2023 | Apr 18, 2023 | FATE | Officer | Form 144 notice | 2,532 | $17k | Notice | SEC | |
| Jan 10, 2023 | Jan 11, 2023 | FATE | Chief Medical Officer | Form 4 sale | 7,825 | $41k | 5.2% | Plan not stated | SEC |
| Apr 19, 2022 | Apr 21, 2022 | FATE | Chief Medical Officer | Form 4 sale | 4,062 | $144k | 2.6% | Plan not stated | SEC |
| Jan 11, 2022 | Jan 13, 2022 | FATE | Senior VP Clinical Development | Form 4 sale | 3,965 | $192k | 3.2% | Plan not stated | SEC |
| Dec 10, 2021 | Dec 13, 2021 | FATE | Senior VP Clinical Development | Form 4 sale | 7,500 | $386k | 5.6% | Plan not stated | SEC |
| Apr 16, 2021 | Apr 20, 2021 | FATE | Senior VP Clinical Development | Form 4 sale | 3,275 | $273k | 4.8% | Plan not stated | SEC |